Non-coding RNAs in cardiac inflammation: key drivers in the pathophysiology of heart failure

Cardiovasc Res. 2022 Jul 20;118(9):2058-2073. doi: 10.1093/cvr/cvab192.

Abstract

Heart failure is among the most progressive diseases and a leading cause of morbidity. Despite several advances in cardiovascular therapies, pharmacological treatments are limited to relieve symptoms without curing cardiac injury. Multiple observations point to the involvement of immune cells as key drivers in the pathophysiology of heart failure. In particular, there is a growing recognition that heart failure is related to a prolonged and insufficiently repressed inflammatory response leading to molecular, cellular, and functional cardiac alterations. Over the last decades, non-coding RNAs are recognized as prominent mediators of cardiac inflammation, affecting the function of several immune cells. In the current review, we explore the contribution of the diverse immune cells in the progression of heart failure, revealing mechanistic functions for non-coding RNAs in cardiac immune cells as a new and exciting field of investigation.

Keywords: Cardiac inflammation; Heart failure; Inflammatory cells; ncRNAs.

Publication types

  • Review

MeSH terms

  • Arrhythmias, Cardiac
  • Heart
  • Heart Failure* / genetics
  • Humans
  • Inflammation / genetics
  • MicroRNAs* / genetics
  • RNA, Long Noncoding*

Substances

  • MicroRNAs
  • RNA, Long Noncoding